You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SNDX Exercise Disclosure
Botwood Nicholas A.j. · SEC Form 4 · Filed Jun 12, 2026
Exercise
Calculated transaction value
$0
Botwood Nicholas A.j. Head Of R&d, CMO
SNDX
Transaction date
Jun 12, 2026
Public filing date
Jun 12, 2026
Filing lag
Filed same day
SNDX daily price context
Close on/before transaction
$18.25
Jun 12, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock options (Right to buy) on Common Stock
- Quantity / price
- 31,235 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-269694
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$1.93M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Syndax Pharmaceuticals Inc SNDX | Sale | Jun 12, 2026 | $566.6K |
| Syndax Pharmaceuticals Inc SNDX Current | Exercise | Jun 12, 2026 | $0 |
| Syndax Pharmaceuticals Inc SNDX | Exercise | Jun 12, 2026 | $431.67K |
| Syndax Pharmaceuticals Inc SNDX | Exercise | Jun 11, 2026 | $0 |
| Syndax Pharmaceuticals Inc SNDX | Exercise | Jun 11, 2026 | $311.16K |
| Syndax Pharmaceuticals Inc SNDX | Sale | Jun 11, 2026 | $617.04K |